...
首页> 外文期刊>British Journal of Cancer >Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas
【24h】

Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas

机译:肠肽受体在人胰腺癌和无肿瘤胰腺中的表达

获取原文

摘要

Gut hormones that modulate the growth of normal pancreas may also modulate the growth of cancers originating from pancreas. This study visualized and compared the receptors for cholecystokinin (CCK), bombesin (BBS), secretin and vasoactive intestinal peptide (VIP) in tumour-free tissue sections of human pancreas (n = 10) and pancreatic ductal adenocarcinomas (n = 12) with storage phosphor autoradiography using radioligands. CCK-B receptors, present in control pancreata, were not detected in any of the pancreatic cancers. BBS receptors were visualized in control pancreata, but they were absent in 10 of 12 pancreatic cancers. In 5 of 12 pancreatic cancers, receptors for secretin were visualized, while binding for secretin was present in all tumour-free pancreata. Conversely, no specific binding of VIP was detected in control pancreata but was identified in 3 of 12 pancreatic cancer specimens. It is concluded that the expression of gut peptide receptors in pancreatic cancer differs from that in tumour-free pancreas. Receptors for these peptides are present in only a minority of pancreatic cancer specimens.
机译:调节正常胰腺生长的肠激素也可能调节源自胰腺的癌症的生长。这项研究可视化并比较了人胰腺(n = 10)和胰腺导管腺癌(n = 12)的无肿瘤组织切片中的胆囊收缩素(CCK),蛙皮素(BBS),促胰液素和血管活性肠肽(VIP)受体与使用放射性配体的存储磷光体放射自显影。在任何胰腺癌中均未检出存在于对照胰​​腺中的CCK-B受体。 BBS受体在对照胰腺中可见,但在12种胰腺癌中有10种不存在。在12种胰腺癌中,有5种显示了促胰液素的受体,而在所有无肿瘤的胰腺中都存在促胰液素的结合。相反,在对照胰腺中未检测到VIP的特异性结合,但在12个胰腺癌标本中的3个中鉴定出了VIP。结论是,肠肽受体在胰腺癌中的表达不同于无肿瘤胰腺中的表达。这些肽的受体仅存在于少数胰腺癌标本中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号